PIM
TEVA icon

Perkins Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History

Perkins Investment Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$1.54M Sell
47,990
-26,783
-36% -$914K 0.02% 199
2016
Q4 		$2.71M Buy
74,773
+18,407
+33% +$735K 0.03% 190
2016
Q3 		$2.59M Buy
56,366
+2,045
+4% +$107K 0.04% 185
2016
Q2 		$2.73M Buy
54,321
+1,049
+2% +$55.8K 0.04% 188
2016
Q1 		$2.85M Buy
53,272
+3,066
+6% +$180K 0.04% 198
2015
Q4 		$3.3M Sell
50,206
-30,880
-38% -$1.91M 0.05% 186
2015
Q3 		$4.33M Sell
81,086
-34,713
-30% -$2.25M 0.06% 175
2015
Q2 		$6.84M Sell
115,799
-634,707
-85% -$39.2M 0.08% 184
2015
Q1 		$46.8M Sell
750,506
-618,483
-45% -$36M 0.47% 77
2014
Q4 		$78.7M Sell
1,368,989
-166,112
-11% -$9.25M 0.74% 46
2014
Q3 		$82.5M Sell
1,535,101
-184,531
-11% -$9.78M 0.76% 47
2014
Q2 		$90.1M Sell
1,719,632
-205,198
-11% -$10.5M 0.73% 50
2014
Q1 		$102M Sell
1,924,830
-1,203,766
-38% -$55.6M 0.78% 48
2013
Q4 		$125M Sell
3,128,596
-415,164
-12% -$16.3M 0.87% 41
2013
Q3 		$134M Sell
3,543,760
-258,069
-7% -$10.1M 0.92% 35
2013
Q2 		$149M Buy
+3,801,829
New +$148M 1.01% 20

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Perkins Investment Management's TEVA Position: Q1 2017 in Review

Perkins Investment Management reduced its Teva Pharmaceuticals (TEVA) stake by 36% in Q1 2017, selling an estimated $914K and leaving 47,990 shares worth $1.54M. The position accounts for 0.02% of the portfolio, ranked #199.

Perkins Investment Management first reported a position in TEVA in Q2 2013 and has held it in 16 quarters since. The position peaked at $149M in Q2 2013. 687 funds tracked by Wall St. Rank hold TEVA as of Q1 2017.

  • Perkins Investment Management held 47,990 shares of Teva Pharmaceuticals worth $1.54M as of Q1 2017.
  • Perkins Investment Management sold 26,783 Teva Pharmaceuticals shares in Q1 2017, an estimated $914K.
  • Teva Pharmaceuticals made up 0.02% of Perkins Investment Management's portfolio in Q1 2017, its #199 holding.
  • Perkins Investment Management first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 16 quarters since.
  • Perkins Investment Management's Teva Pharmaceuticals position peaked at $149M in Q2 2013.
  • 687 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2017.

Based on Perkins Investment Management's 13F filing for Q1 2017, filed 15 May 2017.